Pheonix Research Publishes 2026 “Global Connected Glucose Monitoring Device Market Outlook – Press Release”
Global Connected Glucose Monitoring Device Market to Reach USD 37.59 Billion by 2033, Driven by Digital Health Integration and Personalized Diabetes Management
March 2026 | Pheonix Research
The Global Connected Glucose Monitoring Device Market is projected to grow from USD 18.50 billion in 2025 to USD 37.59 billion by 2033, expanding at a CAGR of 9.27% during the forecast period, according to the latest analysis by Pheonix Research.
Market growth is fueled by increasing adoption of continuous glucose monitoring (CGM) systems, digital health integration, and real-time data-driven diabetes management solutions. Rising global prevalence of diabetes, growing awareness of remote patient monitoring, and expanding reimbursement frameworks are driving healthcare providers and patients toward connected glucose monitoring technologies.
Sakshi Dubey, Analyst – Healthcare & Medical Devices at Pheonix Research, stated:
“The connected glucose monitoring device market is rapidly evolving into a digitally integrated, patient-centric ecosystem. Real-time monitoring, mobile connectivity, and personalized diabetes management are no longer optional — they are becoming core differentiators. Post-2025 growth will be defined by interoperability, AI-driven insights, and seamless integration with telehealth platforms.”
Key Market Highlights:
-
North America remains the largest regional market, supported by advanced healthcare infrastructure, high adoption of CGM systems, and favorable reimbursement policies.
-
Asia-Pacific is the fastest-growing region, driven by rising diabetes prevalence, improving healthcare access, and increasing adoption of digital health technologies in countries like China and India.
-
Technological Integration: AI-enabled analytics, smartphone connectivity, and cloud-based monitoring platforms are enhancing patient engagement, accuracy, and real-time decision-making.
-
Product Trends: Continuous glucose monitoring (CGM) devices, including real-time and flash monitoring systems, are gaining traction over traditional glucose meters.
-
Care Delivery Shift: Growing adoption of home-based care and telehealth solutions is accelerating demand for connected and remote monitoring devices.
-
Regulatory & Reimbursement Support: Expanding payer coverage and regulatory approvals are improving accessibility and accelerating market adoption.
The competitive landscape is highly competitive and moderately fragmented, with key players including Dexcom, Abbott, Medtronic, Roche, Senseonics, and Tandem Diabetes Care leveraging innovation, strategic partnerships, and digital ecosystem expansion to maintain leadership. Barriers to entry include high R&D costs, regulatory compliance requirements, and the need for advanced technological capabilities.
Pheonix Research’s report provides in-depth insights into market trends, segmentation by end-user, application, product type, distribution channel, and connectivity technology, regional dynamics, competitive benchmarking, and long-term growth opportunities within the Global Connected Glucose Monitoring Device Market.
📈 For a detailed look at the full report, visit:
👉https://www.pheonixresearch.com/healthcare/medical-devices/market-report/global-usb-glucose-monitoring-device-market/
About Pheonix Research
Pheonix Research is a global market intelligence and strategic advisory firm delivering data-driven insights across healthcare, medical devices, and other high-growth sectors. Through advanced forecasting tools and AI-backed analytics, the firm helps stakeholders identify emerging opportunities and achieve sustainable competitive advantage.
Media Contact:
Pheonix Research
Email: Media@pheonixresearch.com
Website: www.pheonixresearch.com